000 01372 a2200349 4500
005 20250516181655.0
264 0 _c20140806
008 201408s 0 0 ger d
022 _a2212-0289
024 7 _a10.1016/j.zefq.2013.04.031
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUjeyl, Mariam
245 0 0 _a[The costs of new drugs compared to current standard treatment].
_h[electronic resource]
260 _bZeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
_c2013
300 _a461-7 p.
_bdigital
500 _aPublication Type: Comparative Study; English Abstract; Journal Article
650 0 4 _aCost Savings
_xeconomics
650 0 4 _aCost-Benefit Analysis
_xeconomics
650 0 4 _aDrug Approval
_xeconomics
650 0 4 _aDrug Costs
_xlegislation & jurisprudence
650 0 4 _aDrugs, Generic
_xeconomics
650 0 4 _aDrugs, Investigational
_xeconomics
650 0 4 _aEvidence-Based Medicine
_xeconomics
650 0 4 _aGermany
650 0 4 _aHumans
650 0 4 _aNational Health Programs
_xeconomics
650 0 4 _aPrescription Drugs
_xeconomics
700 1 _aSchlegel, Claudia
700 1 _aGundert-Remy, Ursula
773 0 _tZeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
_gvol. 107
_gno. 7
_gp. 461-7
856 4 0 _uhttps://doi.org/10.1016/j.zefq.2013.04.031
_zAvailable from publisher's website
999 _c23271838
_d23271838